Literature DB >> 17823370

Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium.

Mathilda T M Mommersteeg1, Nigel A Brown, Owen W J Prall, Corrie de Gier-de Vries, Richard P Harvey, Antoon F M Moorman, Vincent M Christoffels.   

Abstract

The pulmonary vein is sleeved by myocardium, which is a major source of atrial fibrillation and is involved in congenital sinus venosus defects. Little is known about the cellular origin and mechanism of formation of the pulmonary myocardium. We observed a biphasic process of pulmonary myocardium formation in mice. Firstly, a myocardial cell population forms de novo at the connection of the pulmonary vein and the atrium. Genetic labeling revealed that atrial cells do not contribute to this population, indicating it forms by differentiation of pulmonary mesenchymal cells. Secondly, these pulmonary myocardial cells initiate a phase of rapid proliferation and form the pulmonary myocardial sleeve. Pitx2c-deficient mice do not develop a pulmonary myocardial sleeve because they fail to form the initial pulmonary myocardial cells. Genetic-labeling analyses demonstrated that whereas the systemic venous return derives from Nkx2-5-negative precursors, the pulmonary myocardium derives from Nkx2-5-expressing precursors, indicating a distinct origin of the 2 venous systems. Nkx2-5 and its target gap-junction gene Cx40 are expressed in the atria and in the pulmonary myocardium but not in the systemic venous return, which expresses the essential pacemaker channel Hcn4. When Nkx2-5 protein level was lowered in a hypomorphic model, the pulmonary myocardium switched to a Cx40-negative, Hcn4-positive phenotype resembling that of the systemic venous return. In conclusion, our data suggest a cellular mechanism for pulmonary myocardium formation and highlight the key roles played by Pitx2c and Nkx2-5 in its formation and identity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823370     DOI: 10.1161/CIRCRESAHA.107.161182

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  135 in total

1.  Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification.

Authors:  Jun Wang; Elzbieta Klysik; Subeena Sood; Randy L Johnson; Xander H T Wehrens; James F Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation.

Authors:  Babar Parvez; Joseph Vaglio; Shane Rowan; Raafia Muhammad; Gayle Kucera; Tanya Stubblefield; Shannon Carter; Dan Roden; Dawood Darbar
Journal:  J Am Coll Cardiol       Date:  2012-06-20       Impact factor: 24.094

3.  PITX2: a master regulator of cardiac channelopathy in atrial fibrillation?

Authors:  Na Li; Dobromir Dobrev; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2016-01-17       Impact factor: 10.787

Review 4.  Genome-wide association studies of late-onset cardiovascular disease.

Authors:  J Gustav Smith; Christopher Newton-Cheh
Journal:  J Mol Cell Cardiol       Date:  2015-04-11       Impact factor: 5.000

5.  Genetic mutations as risk predictors of atrial fibrillation recurrence after catheter ablation?

Authors:  Jennifer L Hall; Ana Barac; Emelia J Benjamin
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

6.  Cardiac origin of smooth muscle cells in the inflow tract.

Authors:  Haruko Nakano; Estrelania Williams; Masahiko Hoshijima; Mika Sasaki; Susumu Minamisawa; Kenneth R Chien; Atsushi Nakano
Journal:  J Mol Cell Cardiol       Date:  2010-10-23       Impact factor: 5.000

7.  Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation.

Authors:  Stefan Kääb; Dawood Darbar; Charlotte van Noord; Josée Dupuis; Arne Pfeufer; Christopher Newton-Cheh; Renate Schnabel; Seiko Makino; Moritz F Sinner; Prince J Kannankeril; Britt M Beckmann; Subbarao Choudry; Brian S Donahue; Jan Heeringa; Siegfried Perz; Kathryn L Lunetta; Martin G Larson; Daniel Levy; Calum A MacRae; Jeremy N Ruskin; Annette Wacker; Albert Schömig; H-Erich Wichmann; Gerhard Steinbeck; Thomas Meitinger; André G Uitterlinden; Jacqueline C M Witteman; Dan M Roden; Emelia J Benjamin; Patrick T Ellinor
Journal:  Eur Heart J       Date:  2009-01-13       Impact factor: 29.983

8.  Common genetic polymorphism at 4q25 locus predicts atrial fibrillation recurrence after successful cardioversion.

Authors:  Babar Parvez; M Benjamin Shoemaker; Raafia Muhammad; Rachael Richardson; Lan Jiang; Marcia A Blair; Dan M Roden; Dawood Darbar
Journal:  Heart Rhythm       Date:  2013-02-19       Impact factor: 6.343

Review 9.  New advances in the genetic basis of atrial fibrillation.

Authors:  Saagar Mahida; Patrick T Ellinor
Journal:  J Cardiovasc Electrophysiol       Date:  2012-10-15

10.  BMP/SMAD1 signaling sets a threshold for the left/right pathway in lateral plate mesoderm and limits availability of SMAD4.

Authors:  Milena B Furtado; Mark J Solloway; Vanessa J Jones; Mauro W Costa; Christine Biben; Orit Wolstein; Jost I Preis; Duncan B Sparrow; Yumiko Saga; Sally L Dunwoodie; Elizabeth J Robertson; Patrick P L Tam; Richard P Harvey
Journal:  Genes Dev       Date:  2008-11-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.